Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Digestive Care
Digestive Care
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Pertzye
Pancrelipase
2012-05-17
—
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Pancrelipase
neoplasms
,
cerebral palsy
,
hypoglycemia
,
type 1 diabetes mellitus
,
renal cell carcinoma
,
carcinoma
,
hepatocellular carcinoma
,
short bowel syndrome
,
pancreatic ductal carcinoma
,
malnutrition
,
malabsorption syndromes
,
pancreatectomy
,
abdominal pain
,
sepsis
,
child nutrition disorders
,
chronic kidney failure
,
renal insufficiency
,
eructation
,
exocrine pancreatic insufficiency
,
cystic fibrosis
,
pancreatic neoplasms
,
chronic pancreatitis
,
fibrosis
,
pancreatitis
,
steatorrhea
,
irritable bowel syndrome
,
diarrhea
,
dyspepsia
,
syndrome
,
celiac disease
,
recurrence
,
colonic polyps
,
polyps
,
bifidobacterium
,
gastrectomy
,
pancreaticoduodenectomy
,
digestive system diseases
,
pancreatic diseases
,
gastrointestinal diseases
,
lung neoplasms
,
hemorrhage
,
postoperative complications
,
pancreatic fistula
,
gastroparesis
,
fistula
,
acute hemorrhagic pancreatitis
,
liver cirrhosis
,
obesity
,
respiratory tract diseases
,
inborn genetic diseases
,
rare diseases
,
endoscopic retrograde cholangiopancreatography
Aspartame
leukemia
,
neoplasms
,
atopic dermatitis
,
myeloid leukemia acute
,
multiple myeloma
,
lymphoma
,
plasma cell neoplasms
,
large b-cell lymphoma diffuse
,
type 2 diabetes mellitus
,
diabetes mellitus
,
recurrence
,
opioid-related disorders
,
alzheimer disease
,
huntington disease
,
eczema
,
dermatitis
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
covid-19
,
meningioma
,
inflammation
,
triple negative breast neoplasms
,
serogroup b neisseria meningitidis
,
crush injuries
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
down syndrome
,
syndrome
,
cognitive dysfunction
,
central nervous system neoplasms
,
solitary fibrous tumors
,
neurofibromatosis 1
,
neurofibromatoses
,
hemangioblastoma
,
hemangiopericytoma
,
neurofibroma
,
streptococcal infections
,
thyroid neoplasms
,
thyroid diseases
,
pain
,
breast neoplasms
,
sickle cell anemia
,
pneumonia
,
renal insufficiency
,
headache
,
tension-type headache
,
toothache
,
meningitis
,
rheumatoid arthritis
,
arthritis
,
bacterial pneumonia
,
juvenile arthritis
,
psoriatic arthritis
,
ankylosing spondylitis
,
carotid artery diseases
,
atherosclerosis
,
ulcerative colitis
,
colitis
,
ulcer
,
meningococcal meningitis
,
stroke
,
thromboembolism
,
hiv infections
,
tuberculosis
,
acquired immunodeficiency syndrome
,
immune reconstitution inflammatory syndrome
,
seizures
,
alopecia areata
,
alopecia
,
hair diseases
,
healthy volunteers/patients
,
infections
,
communicable diseases
,
intraabdominal infections
,
smoking cessation
,
neuroendocrine tumors
,
islet cell adenoma
,
psychomotor agitation
,
schizophrenia
,
renal cell carcinoma
,
carcinoma
,
gaucher disease
,
tobacco use disorder
,
acromegaly
,
fatigue
Nadide
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use